Mutations and Binding Sites of Human Transcription Factors

Mutations in any genome may lead to phenotype characteristics that determine ability of an individual to cope with adaptation to environmental challenges. In studies of human biology, among the most interesting ones are phenotype characteristics that determine responses to drug treatments, response to infections, or predisposition to specific inherited diseases. Most of the research in this field has been focused on the studies of mutation effects on the final gene products, peptides, and their alterations. Considerably less attention was given to the mutations that may affect regulatory mechanism(s) of gene expression, although these may also affect the phenotype characteristics. In this study we make a pilot analysis of mutations observed in the regulatory regions of 24,667 human RefSeq genes. Our study reveals that out of eight studied mutation types, “insertions” are the only one that in a statistically significant manner alters predicted transcription factor binding sites (TFBSs). We also find that 25 families of TFBSs have been altered by mutations in a statistically significant manner in the promoter regions we considered. Moreover, we find that the related transcription factors are, for example, prominent in processes related to intracellular signaling; cell fate; morphogenesis of organs and epithelium; development of urogenital system, epithelium, and tube; neuron fate commitment. Our study highlights the significance of studying mutations within the genes regulatory regions and opens way for further detailed investigations on this topic, particularly on the downstream affected pathways.

[1]  Martha L Bulyk,et al.  Precise temporal control of the eye regulatory gene Pax6 via enhancer-binding site affinity. , 2010, Genes & development.

[2]  F. Hu,et al.  Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. , 2009, American journal of epidemiology.

[3]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology , 2003, Nucleic Acids Res..

[4]  J. Hermisson,et al.  The Genetic Basis of Phenotypic Adaptation I: Fixation of Beneficial Mutations in the Moving Optimum Model , 2009, Genetics.

[5]  M. Olivier A haplotype map of the human genome. , 2003, Nature.

[6]  P. Stenson,et al.  The Human Gene Mutation Database: 2008 update , 2009, Genome Medicine.

[7]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[8]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[9]  W. Bao,et al.  Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. , 2010, American journal of epidemiology.

[10]  Tatiana A. Tatusova,et al.  NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..

[11]  Vladimir B. Bajic,et al.  dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes , 2011, PloS one.

[12]  R. Rad,et al.  Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer. , 2009, Cytokine.

[13]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  K. Xia,et al.  Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II , 2011, Human Genetics.

[15]  M. Gerstein,et al.  Variation in Transcription Factor Binding Among Humans , 2010, Science.

[16]  H. Ghofrani,et al.  A Functional Single-Nucleotide Polymorphism in the TRPC6 Gene Promoter Associated With Idiopathic Pulmonary Arterial Hypertension , 2009, Circulation.

[17]  Peter B. McGarvey,et al.  Infrastructure for the life sciences: design and implementation of the UniProt website , 2009, BMC Bioinformatics.

[18]  W. Miller,et al.  Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies , 2011, Front. Pharmacol..

[19]  S. Richard,et al.  A new locus‐specific database (LSDB) for mutations in the folliculin (FLCN) gene , 2010, Human mutation.

[20]  Timos K. Sellis,et al.  miRGen 2.0: a database of microRNA genomic information and regulation , 2009, Nucleic Acids Res..

[21]  J. Schwob,et al.  Expression of Pax6 and Sox2 in adult olfactory epithelium , 2010, The Journal of comparative neurology.

[22]  Joaquín Dopazo,et al.  PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes , 2006, Nucleic Acids Res..

[23]  M. Busslinger,et al.  Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. , 2009, Immunity.

[24]  E. Abercrombie,et al.  In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease , 2011, Front. Syst. Neurosci..

[25]  David Haussler,et al.  The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..

[26]  O. Madsen,et al.  The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells , 2009, Cell.

[27]  J. Caboche,et al.  Huntington’s Disease and Striatal Signaling , 2011, Front. Neuroanat..

[28]  M. Drumm,et al.  Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease , 2009, Nature.

[29]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[30]  V. Bajic,et al.  A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis , 2009, Genes and Immunity.

[31]  Amber C. Donahue,et al.  Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome , 2010, BMC Medical Genetics.

[32]  Samir K. Brahmachari,et al.  dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation , 2009, BMC Bioinformatics.

[33]  C. Norez,et al.  CFTR and Ca2+ Signaling in Cystic Fibrosis , 2011, Front. Pharmacol..

[34]  Alan F. Scott,et al.  McKusick's Online Mendelian Inheritance in Man (OMIM®) , 2008, Nucleic Acids Res..

[35]  Sridhar Hannenhalli,et al.  The evolution of Fox genes and their role in development and disease , 2009, Nature Reviews Genetics.

[36]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[37]  Jong Bhak,et al.  SNP@Promoter: a database of human SNPs (Single Nucleotide Polymorphisms) within the putative promoter regions , 2008, BMC Bioinformatics.

[38]  T. González-Hernández,et al.  Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease , 2010, Front. Neuroanat..

[39]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[40]  M. Bennett Galactosemia diagnosis gets an upgrade. , 2010, Clinical chemistry.

[41]  Ligang Wu,et al.  PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits , 2006, Nucleic Acids Res..

[42]  R. S. Lindoso,et al.  Renal recovery after injury: the role of Pax-2. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..